安徽金太阳生化药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
85
NMPA:85
Drug Approvals
Diprophylline Injection
- Product Name
- 二羟丙茶碱注射液
- Approval Number
- 国药准字H20253710
- Approval Date
- Mar 25, 2025
NMPA
Clindamycin Phosphate Injection
- Product Name
- 克林霉素磷酸酯注射液
- Approval Number
- 国药准字H20065780
- Approval Date
- Dec 22, 2021
NMPA
Pefloxacin Mesylate Injection
- Product Name
- 甲磺酸培氟沙星注射液
- Approval Number
- 国药准字H20066280
- Approval Date
- Dec 22, 2021
NMPA
Compound Cerebroprotein HydroLysate Tablets
- Product Name
- 复方脑蛋白水解物片
- Approval Number
- 国药准字H34022261
- Approval Date
- Jan 22, 2021
NMPA
Dexamethasone Sodium Phosphate Injection
- Product Name
- 地塞米松磷酸钠注射液
- Approval Number
- 国药准字H34023513
- Approval Date
- Jan 7, 2021
NMPA
Ocular Extractives Injection
- Product Name
- 眼氨肽注射液
- Approval Number
- 国药准字H34022263
- Approval Date
- Jan 7, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
No trials found
News
No news found